At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users
In Brief
A Phase 2 clinical trial evaluating 40/0mg taken first, 80/0mg taken first, and 3 other interventions for Opioid Abuse. Completed, enrolled 49 participants across 1 site.
Detailed Summary
The primary objective of this study is to compare the relative abuse potential of two different doses of orally administered Acurox Tablets to orally administered immediate-release (IR) oxycodone HCl tablets in non-dependent recreational opioid users.
Study Details
Timeline
Interventions
8x Oxycodone/Niacin 5/0mg tablets All arms taken with a 48 hour washout between doses
8x Oxycodone/Niacin 10/0mg tablets All arms taken with a 48 hour washout between doses
8x Oxycodone/Niacin 5/30mg tablets All arms taken with a 48 hour washout between doses
8x Oxycodone/Niacin 10/60mg tablets All arms taken with a 48 hour washout between doses
Placebo All arms taken with a 48 hour washout between doses